Use of PROC MIXED in the analysis of repeated measures data from a clinical trial in obsessive compulsive disorder

被引:0
|
作者
Bushnell, W [1 ]
Steiner, M [1 ]
机构
[1] SmithKline Beecham, Collegeville, PA 19426 USA
关键词
D O I
暂无
中图分类号
TP31 [计算机软件];
学科分类号
081202 ; 0835 ;
摘要
The subject of this paper is the analysis of data from a randomized, parallel group, multicenter clinical trial in patients with Obsessive Compulsive Disorder (OCD). The purpose of the study was to evaluate the efficacy and safety of three dose levels of Paxil(TM)* (paroxetine HCl) versus placebo. The level of the patients' illness was measured using the Yale Brown Obsessive Compulsive Scale (YBOCS) at baseline and at weeks 1, 2, 3, 4, 6, 8, 10, and 12. The data set included data points which were missing due to skipped visits and patient dropouts. PROC MIXED of the SAS System was used in two alternative approaches to the analysis of the data from this study. The first is a repeated measures analysis. Secondly, PROC MIXED was used in a random coefficient regression analysis. In this analysis the hypothesis of interest was the differences in slopes (rates of improvement) for the doses of Paxil and placebo.
引用
收藏
页码:1341 / 1346
页数:6
相关论文
共 50 条
  • [31] Clinical features distinguishing patients with Tourette's syndrome and obsessive-compulsive disorder from patients with obsessive-compulsive disorder without tics
    Petter, T
    Richter, MA
    Sandor, P
    JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (09) : 456 - 459
  • [32] Obsessive Compulsive Disorder Case Study from the Contingential Analysis Perspective
    Lourdes Rodriguez-Campuzano, Maria
    PENSANDO PSICOLOGIA, 2018, 14 (23):
  • [33] Obsessive-compulsive disorder clinical staging: From endophenotype to behavioral addiction
    Grassi, Giacomo
    Stefano, Pallanti
    JOURNAL OF BEHAVIORAL ADDICTIONS, 2013, 2 : 15 - 15
  • [34] OBSESSIVE-COMPULSIVE DISORDER CLINICAL STAGING: FROM ENDOPHENOTYPE TO BEHAVIORAL ADDICTION
    Grassi, G.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [35] Defining response in clinical trials for obsessive-compulsive disorder: A signal detection analysis of the Yale-Brown obsessive compulsive scale
    Tolin, DE
    Abramowitz, JS
    Diefenbach, GJ
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (12) : 1549 - 1557
  • [36] Group Metacognitive Therapy for Obsessive-Compulsive Disorder in a Routine Clinical Setting: An Open Trial
    Carter, Janet D.
    Helliwell, Erin
    Jordan, Jenny
    Woolcock, Colette
    Bell, Caroline
    Gilbert, Claire
    BEHAVIOUR CHANGE, 2023, 40 (02) : 117 - 132
  • [37] Evaluation of Clonidine Augmentation Therapy for Obsessive-Compulsive Disorder Treatment; a Randomized Clinical Trial
    Akouchakian, Shahla
    Tarrahi, Mohammad Javad
    Mohebati, Elham
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2021, 15 (03)
  • [38] Predictors of clinical worsening during a discontinuation trial of serotonin reuptake inhibitors for obsessive compulsive disorder
    Tyler, Jeremy
    Gallagher, Thea
    Wheaton, Michael G.
    Hamlett, Gabriella E.
    Rosenfield, Ben
    Rosenfield, David
    Simpson, Helen B.
    Foa, Edna B.
    JOURNAL OF ANXIETY DISORDERS, 2024, 101
  • [39] CLOMIPRAMINE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER .1. A CONTROLLED CLINICAL-TRIAL
    THOREN, P
    ASBERG, M
    CRONHOLM, B
    JORNESTEDT, L
    TRASKMAN, L
    ARCHIVES OF GENERAL PSYCHIATRY, 1980, 37 (11) : 1281 - 1285
  • [40] Cognitive-behavioral group therapy in obsessive-compulsive disorder: A randomized clinical trial
    Cordioli, AV
    Heldt, E
    Bochi, DB
    Margis, R
    de Sousa, MB
    Tonello, JF
    Manfro, GG
    Kapczinski, F
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2003, 72 (04) : 211 - 216